Tetsuji Takayama
Professor
Faculty of Medicine
University of Tokushima
Japan
Biography
Tetsuji Takayama has done his Graduated in Medicine from Sapporo Medical University in 1991. Currently he is working as Professor in Faculty of Medicine in Tokushima University. His research interests are Gastroenterology, Chemotherapy, Clinical Edema. Several papers of his work were published in reputed international journals. He is the member ofThe Japanese Society of Gastroenterology, Japan Gastroenterological Endoscopy Society, The Japanese Society of Internal Medicine, Japan Society of Clinical Oncology.
Research Interest
Gastroenterology, Chemotherapy, Clinical Edema, Diagnosis and treatment of gastrointestinal cancer.
Publications
-
Shinji Kitamura, Naoki Muguruma, Koichi Okamoto, Toshihito Tanahashi, Akira Fukuya, Kumiko Tanaka, Daisaku Fujimoto, Tetsuo Kimura, Hiroshi Miyamoto, Yoshimi Bando, Hisashi Takeuchi, Masako Shiba and Tetsuji Takayama. Clinicopathological Assessment of Gastric Xanthomas as Potential Predictive Markers of Gastric Cancer. Digestion. 2017, 96(4): 199-206.
-
Yasuyuki Okada, Tetsuo Kimura, Tadahiko Nakagawa, Koichi Okamoto, Akira Fukuya, Takahiro Goji, Shota Fujimoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Yasushi Tsuji, Toshiya Okahisa and Tetsuji Takayama. EGFR Down-regulation After anti-EGFR Therapy Predicts the Anti-tumor Effect in Colorectal Cancer. Molecular Cancer Research. 2017, 15(10): 1445-1454.
-
Yasushi Sato, Masahiro Hirakawa, Hiroyuki Ohnuma, Minoru Takahashi, Tetsuro Okamoto, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Tomohisa Furuhata, Ichiro Takemasa, Junji Kato and Tetsuji Takayama. A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study. Cancer Chemotherapy and Pharmacology. 2017.